Additionally, prolyl hydroxylase domain (PHD) inhibitors, such as the clinical drug Roxadustat (FG-4592), are capable of treating a variety of recalcitrant anaemiaincluding refractory anaemia, inflammatory anaemias, and chemotherapy-associated anaemiasby activating the HIF-2 axis [100]
Mounjaro significantly reduced HbA1c levels in 5 clinical trials (source: Lilly website) Obesity was common among clinical trial participants, with most participants having a BMI between 32 and 34 at enrollment
Reber, S
The exact amount depends on your body size, goal weight, training, medical history, digestion, kidney health, and total calorie intake
doi: 10.1007/s13300-020-00786-1